Magneceutical Therapy: Phase II data

A double-blind, placebo-controlled, U.S. Phase II trial in 13 evaluable patients showed that Pico-Tesla's Magneceutical Therapy given 4 times weekly for 2 weeks as an adjunctive therapy to oral medica...